Close

Global Pharmaceutical Contract Packaging Is On The Rise

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Grand View Research’s pharmaceutical packaging industry data compilation encompasses market size projections, trade data, pricing intelligence, competitive benchmarks, macro-environmental analysis, and studies on regulatory and technological frameworks. This information is systematically evaluated within the database, and presented in the form of detailed sectoral outlook reports, summary presentations for specific research areas, and a statistics e-book.

In plastic pharmaceutical packaging, the global market reached a value of $43.4 billion in 2021, with a projected 9.1% CAGR, driven by the advantages of plastic such as lightweight, moldability, and cost-effectiveness. Polypropylene (PP) will dominate in 2022 due to its unique properties. PET is also growing, especially for liquid oral drug packaging.

The parenteral containers market, valued at $7 billion in 2021 and expected to grow at a 13.9% CAGR during 2022-2030, includes glass and plastic containers. Stringent regulations, driven by biotech drugs and cost concerns, emphasize drug delivery product quality and shelf life. Manufacturers like SCHOTT AG and Gerresheimer AG employ advanced technologies for quality control.

Primary pharmaceutical packaging, valued at $88.5 billion in 2021 with a 9.7% CAGR, protects drugs and facilitates dispensing and dosing. It plays a vital role in drug safety, especially in the biologics market.

The pharmaceutical contract packaging market, worth $42.9 billion in 2021 and expected to grow at a 9.9% CAGR, benefits from stringent quality standards and outsourcing to reduce production costs and accelerate market entry. This addresses challenges faced by small pharmaceutical companies.

North America holds the largest revenue share at 32.7% in 2019, while Asia Pacific is the fastest-growing region, driven by contract packaging providers and increased outsourcing to emerging countries like India.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back